Showing results (11-20 of 24,981) with videos related to
Sort By:
Pageof 2,499
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Recombinant clotting factors: a review of current clinical statusJ M LusherSeminars in Thrombosis and Hemostasis|August 5, 2000
Inhibitor antibodies to factor VIII and factor IX: managementJ M LusherBailliere'S Best Practice & Research. Clinical Haematology|October 13, 2000
Inhibitors in young boys with haemophiliaJ M LusherHaemostasis|September 1, 1994
Response to 1-deamino-8-D-arginine vasopressin in von Willebrand diseaseJ M LusherEuropean Journal of Haematology. Supplementum|January 12, 1999
Early treatment with recombinant factor VIIa results in greater efficacy with less productJ M LusherHaemostasis|January 1, 1996
Recombinant factor VIIa (NovoSeven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitorsJ M LusherHaemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP--a survey of European physiciansJ M LusherProgress in Clinical and Biological Research|January 1, 1984
Assessment of response to treatment and design of clinical trialsJ M LusherProgress in Clinical and Biological Research|January 1, 1984
Controlled clinical trials with prothrombin complex concentratesJ M LusherSeminars in Thrombosis and Hemostasis|July 5, 2002
First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor developmentJeanne M LusherPageof 2,499